Envestnet Asset Management Inc. Cuts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Envestnet Asset Management Inc. lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 8.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,321 shares of the company’s stock after selling 8,969 shares during the quarter. Envestnet Asset Management Inc. owned about 0.07% of Henry Schein worth $7,487,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Cambridge Investment Research Advisors Inc. raised its stake in shares of Henry Schein by 2.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after purchasing an additional 122 shares during the last quarter. Contravisory Investment Management Inc. raised its stake in shares of Henry Schein by 2.1% during the second quarter. Contravisory Investment Management Inc. now owns 6,895 shares of the company’s stock worth $559,000 after purchasing an additional 141 shares during the last quarter. CWM LLC grew its holdings in Henry Schein by 3.1% during the second quarter. CWM LLC now owns 4,847 shares of the company’s stock worth $393,000 after acquiring an additional 144 shares during the period. Studio Investment Management LLC grew its holdings in Henry Schein by 3.9% during the fourth quarter. Studio Investment Management LLC now owns 4,160 shares of the company’s stock worth $332,000 after acquiring an additional 155 shares during the period. Finally, Kentucky Retirement Systems Insurance Trust Fund grew its holdings in Henry Schein by 3.4% during the third quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 4,878 shares of the company’s stock worth $321,000 after acquiring an additional 161 shares during the period. Hedge funds and other institutional investors own 93.31% of the company’s stock.

Henry Schein Stock Down 0.0 %

Henry Schein stock opened at $68.75 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.91 and a current ratio of 1.72. The firm has a market capitalization of $8.98 billion, a price-to-earnings ratio of 20.46, a price-to-earnings-growth ratio of 2.45 and a beta of 0.87. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $89.72. The stock’s fifty day moving average is $70.18 and its two-hundred day moving average is $74.99.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, November 13th. The company reported $1.32 EPS for the quarter, meeting analysts’ consensus estimates of $1.32. The business had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a return on equity of 16.22% and a net margin of 3.51%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.15 earnings per share. Analysts predict that Henry Schein, Inc. will post 4.62 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently weighed in on HSIC shares. Stifel Nicolaus raised Henry Schein from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Friday, November 10th. TheStreet lowered Henry Schein from a “b-” rating to a “c+” rating in a report on Thursday, November 2nd. Bank of America dropped their price objective on Henry Schein from $76.00 to $75.00 in a report on Monday, August 7th. Credit Suisse Group reaffirmed an “outperform” rating and set a $96.00 price objective on shares of Henry Schein in a report on Tuesday, August 8th. Finally, Barrington Research lowered their target price on Henry Schein from $90.00 to $82.00 and set an “outperform” rating on the stock in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $78.75.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.